Literature DB >> 2618820

Vestibulospinal evoked potential versus motor evoked potential monitoring in experimental spinal cord injuries of cats.

M Zileli1, M Taniguchi, C Cedzich, J Schramm.   

Abstract

Changes in vestibulospinal evoked potentials (VsEP) and motor evoked potentials (MEP) were examined in 10 cats before and after two different weight-dropping spinal cord injuries. In six animals somatosensory evoked potentials (SEP) were also monitored. The recordings were done from epidural spinal cord electrodes. Before and after severe and light weight-dropping spinal cord injuries all 3 modalities were recorded at the same time intervals till the end of 4th hour postinjury. According to a scoring system, evoked potential changes below and above the level of injury were monitored, and compared with each other. This study showed that the different motor stimulation methods use different descending spinal tracts, and both can be useful as a monitoring tool. Both descending tracts carrying VsEP and MEP had similarly remarkable changes after severe spinal cord injury. These consisted of major deformation, development of an evoked injury potential and complete potential loss. During the 4 hour monitoring period, no case showed EP recovery in the severe injury group. Light spinal cord injury caused somewhat more deterioration in MEPs than VsEP. The higher numbers of severe potential alterations in the lightly injured animals suggest that MEP is a more sensitive method for spinal cord monitoring compared to VsEP and also to SEP. On the other hand, this sensitivity might be a disadvantage during intraoperative monitoring, if MEP alone were used.

Entities:  

Mesh:

Year:  1989        PMID: 2618820     DOI: 10.1007/bf01410530

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  29 in total

1.  Preoperative determination of the level of spinal cord lesions from the killed end potential.

Authors:  Y Katayama; T Tsubokawa; T Yamamoto; T Hirayama; S Maejima
Journal:  Surg Neurol       Date:  1988-02

2.  Clinical experience with motor and cerebellar evoked potential monitoring.

Authors:  W J Levy
Journal:  Neurosurgery       Date:  1987-01       Impact factor: 4.654

Review 3.  The pathophysiological response to spinal cord injury. The current status of related research.

Authors:  J L Osterholm
Journal:  J Neurosurg       Date:  1974-01       Impact factor: 5.115

4.  Clinical signs and evoked response alterations associated with chronic experimental cord compression.

Authors:  J Schramm; T Shigeno; M Brock
Journal:  J Neurosurg       Date:  1983-05       Impact factor: 5.115

5.  Experimental investigation on the spinal cord evoked injury potential.

Authors:  J Schramm; R Krause; T Shigeno; M Brock
Journal:  J Neurosurg       Date:  1983-09       Impact factor: 5.115

6.  Spinal evoked potentials from the motor tracts.

Authors:  W J Levy
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

7.  Vestibulospinal monitoring in experimental spinal trauma.

Authors:  W Young; J Tomasula; V DeCrescito; E S Flamm; J Ransohoff
Journal:  J Neurosurg       Date:  1980-01       Impact factor: 5.115

8.  Neurological outcome correlated with spinal evoked potentials in a spinal cord ischemia model.

Authors:  M K Cheng; C Robertson; R G Grossman; R Foltz; V Williams
Journal:  J Neurosurg       Date:  1984-04       Impact factor: 5.115

9.  Motor evoked potential in cats with acute spinal cord injury.

Authors:  W Levy; M McCaffrey; D York
Journal:  Neurosurgery       Date:  1986-07       Impact factor: 4.654

10.  Postoperative paraplegia with preserved intraoperative somatosensory evoked potentials. Case report.

Authors:  H H Ginsburg; A G Shetter; P A Raudzens
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

View more
  1 in total

1.  Motor versus somatosensory evoked potential changes after acute experimental spinal cord injury in rats.

Authors:  M Zileli; J Schramm
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.